Radiomics

Gliomas are among the most aggressive cancers, with complex diagnostic processes. Existing glioma segmentation methods often struggle with high variability in imaging data and inadequate optimization. Furthermore, radiomic analysis is typically applied only after segmentation is finished, limiting its ability to inform the segmentation process itself. To address these challenges, we propose a novel radiomics-enhanced fused residual multiparametric 3D network (ReFRM3D) for brain tumor characterization. The framework is based on a 3D U-Net architecture and features multi-scale feature fusion, hybrid upsampling, and an extended residual skip mechanism. Additionally, we introduce a radiomic conditioning mechanism that extracts texture and intensity descriptors from an intermediate coarse segmentation and re-injects them into the decoder to refine the final output. Experimental results on BraTS2019, BraTS2020, and BraTS2021 show strong performance, with mean DSC values of 93.45%, 93.61%, and 92.06%, respectively, across whole tumor, enhancing tumor, and tumor core regions. Compared with recent models, ReFRM3D improves average DSC by 5.79%, 7.25%, and 0.96% on these datasets. Our model also generalized well on the BraTS-Africa dataset with an average DSC of 87.8%, despite differences in scanner field strength and patient demographics.

Quantitative assessment of muscle MRI is crucial for monitoring neuromuscular disorders (NMD). This study introduces an automated radiomic phenotyping framework based on original features engineered across five main architectural domains: quantitative morphometry, spatial distribution, geometric shape, interactions between progressive fat replacement stages, and graph-based topology. Utilizing 1184 MRI scans from the CoMPaSS-NMD project, we map the complex 3D architecture of heterogeneous intramuscular lipodegeneration into objective, morphologically interpretable biomarkers. We introduce a graph-based skeletonization of fat infiltrates to quantify muscle architectural changes, establishing a multi-dimensional extension of traditional, spatially-agnostic volume metrics by mapping topological networks across the entire 3D muscle volume. Statistical screening via non-parametric Kruskal-Wallis analysis confirmed the discriminative power of these novel descriptors across the genetic hierarchy. Notably, topological network metrics (e.g., SF1_Skel_Nodes, $\epsilon^2$ = 0.2656) and interface dynamics metrics (e.g., SF2_To_SF1_Dist_Min, $\epsilon^2$ = 0.2092) demonstrated substantial effect sizes, providing deeper structural insights than classical volumetric assessments. Post-hoc pairwise evaluations and UMAP projections further indicated the capability of these topological and 3D geometric invariants to capture disease-specific macroscopic infiltration patterns. These results demonstrate that global architectural features represent a highly promising class of biomarkers for differential diagnosis, offering new avenues for tracking longitudinal disease dynamics in neuromuscular diagnostics. The developed automated feature extraction pipeline is integrated and available within the MUSCAT (MUSCle fAt Topology) library.